Motor Imagery and Rehabilitation of Orthopaedic Patients
NCT ID: NCT03370146
Last Updated: 2017-12-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2015-03-17
2018-10-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TKA patients - Experimental Group
Mental training based on Motor Imagery
Patients of the experimental group will be instructed to imagine walking, from a first person perspective, focusing on the kinaesthetic sensations typically associated with the movement. The motor imagery training will be performed using the support of a laptop, on which there will be presented complex static scenes, representing different kind of paths with different landmarks to reach during the mental walking.
Evaluation of gait abilities
All the subjects included in the trial will undergo a series of behavioral test for the evaluation of gai abilities
TKA patients - Control Group 1
Cognitive training
Patients of the control group 1 will undergo a general cognitive training, not based on motor imagery.
Evaluation of gait abilities
All the subjects included in the trial will undergo a series of behavioral test for the evaluation of gai abilities
Healthy subjects - Control Group 2
Evaluation of gait abilities
All the subjects included in the trial will undergo a series of behavioral test for the evaluation of gai abilities
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mental training based on Motor Imagery
Patients of the experimental group will be instructed to imagine walking, from a first person perspective, focusing on the kinaesthetic sensations typically associated with the movement. The motor imagery training will be performed using the support of a laptop, on which there will be presented complex static scenes, representing different kind of paths with different landmarks to reach during the mental walking.
Cognitive training
Patients of the control group 1 will undergo a general cognitive training, not based on motor imagery.
Evaluation of gait abilities
All the subjects included in the trial will undergo a series of behavioral test for the evaluation of gai abilities
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No contraindication to the fMRI exam
Exclusion Criteria
45 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
IRCCS Galeazzi Orthopedic Hospital
Milan, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Sara Zacchetti
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
L3020
Identifier Type: -
Identifier Source: org_study_id